Home2070 • TADAWUL
add
Saudi Pharmaceutical Ind&Mdl Apl CrpSJSC
Previous close
SAR 35.95
Day range
SAR 34.35 - SAR 35.90
Year range
SAR 27.45 - SAR 45.25
Market cap
4.30B SAR
Avg Volume
861.84K
P/E ratio
-
Dividend yield
-
Primary exchange
TADAWUL
Market news
Financials
Income Statement
Revenue
Net income
(SAR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 331.00M | -9.27% |
Operating expense | 100.00M | -50.99% |
Net income | -43.00M | 59.72% |
Net profit margin | -12.99 | 55.60% |
Earnings per share | — | — |
EBITDA | 23.02M | 136.83% |
Effective tax rate | -145.00% | — |
Balance Sheet
Total assets
Total liabilities
(SAR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 276.02M | -27.51% |
Total assets | 4.02B | 5.01% |
Total liabilities | 2.36B | 10.16% |
Total equity | 1.67B | — |
Shares outstanding | 120.00M | — |
Price to book | 2.86 | — |
Return on assets | 0.12% | — |
Return on capital | 0.18% | — |
Cash Flow
Net change in cash
(SAR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -43.00M | 59.72% |
Cash from operations | 133.18M | -4.76% |
Cash from investing | -61.45M | -298.73% |
Cash from financing | -45.55M | 74.50% |
Net change in cash | 28.13M | 131.46% |
Free cash flow | 16.16M | -90.64% |
About
Founded
Jan 20, 1986
Website